Global Self-administered Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21746564 | Publishing Date : 21-Sep-2022 | No. of pages : 107
Detailed TOC of Global Self-administered Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Self-administered Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Injectable Drugs
1.2.3 Inhaled Drugs
1.2.4 Transdermal Drugs
1.3 Market Segment by Application
1.3.1 Global Self-administered Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Cardiovascular Diseases
1.3.3 Diabetes
1.3.4 Osteoporosis
1.3.5 Pain Management
1.3.6 Hormone Replacement
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Self-administered Drugs Market Size (2017-2028)
2.1.1 Global Self-administered Drugs Revenue (2017-2028)
2.1.2 Global Self-administered Drugs Sales (2017-2028)
2.2 Global Self-administered Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Self-administered Drugs Sales by Regions (2017-2022)
2.2.2 Global Self-administered Drugs Revenue by Regions (2017-2022)
2.3 Global Self-administered Drugs Market Size Forecast by Region
2.3.1 Global Self-administered Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Self-administered Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Self-administered Drugs Regions (Countries) Ranking by Market Size
2.5 Self-administered Drugs Market Dynamics
2.5.1 Self-administered Drugs Market Trends
2.5.2 Self-administered Drugs Market Drivers
2.5.3 Self-administered Drugs Market Challenges
2.5.4 Self-administered Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Self-administered Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Self-administered Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Self-administered Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Self-administered Drugs Sales in 2021
3.2 Global Top Manufacturers Self-administered Drugs by Revenue
3.2.1 Global Self-administered Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Self-administered Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Self-administered Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Self-administered Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Self-administered Drugs as of 2021)
3.4 Global Self-administered Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Self-administered Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Self-administered Drugs Market
3.7 Key Manufacturers Self-administered Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Self-administered Drugs Market Size by Type
4.1 Global Self-administered Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Self-administered Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Self-administered Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Self-administered Drugs Price by Type (2017-2022)
4.2 Global Self-administered Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Self-administered Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Self-administered Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Self-administered Drugs Price Forecast by Type (2023-2028)
5 Global Self-administered Drugs Market Size by Application
5.1 Global Self-administered Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Self-administered Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Self-administered Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Self-administered Drugs Price by Application (2017-2022)
5.2 Global Self-administered Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Self-administered Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Self-administered Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Self-administered Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Self-administered Drugs Sales Breakdown by Company
6.1.1 North America Self-administered Drugs Sales by Company (2017-2022)
6.1.2 North America Self-administered Drugs Revenue by Company (2017-2022)
6.2 North America Self-administered Drugs Market Size by Type
6.2.1 North America Self-administered Drugs Sales by Type (2017-2028)
6.2.2 North America Self-administered Drugs Revenue by Type (2017-2028)
6.3 North America Self-administered Drugs Market Size by Application
6.3.1 North America Self-administered Drugs Sales by Application (2017-2028)
6.3.2 North America Self-administered Drugs Revenue by Application (2017-2028)
6.4 North America Self-administered Drugs Market Size by Country
6.4.1 North America Self-administered Drugs Sales by Country (2017-2028)
6.4.2 North America Self-administered Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Self-administered Drugs Sales Breakdown by Company
7.1.1 Europe Self-administered Drugs Sales by Company (2017-2022)
7.1.2 Europe Self-administered Drugs Revenue by Company (2017-2022)
7.2 Europe Self-administered Drugs Market Size by Type
7.2.1 Europe Self-administered Drugs Sales by Type (2017-2028)
7.2.2 Europe Self-administered Drugs Revenue by Type (2017-2028)
7.3 Europe Self-administered Drugs Market Size by Application
7.3.1 Europe Self-administered Drugs Sales by Application (2017-2028)
7.3.2 Europe Self-administered Drugs Revenue by Application (2017-2028)
7.4 Europe Self-administered Drugs Market Size by Country
7.4.1 Europe Self-administered Drugs Sales by Country (2017-2028)
7.4.2 Europe Self-administered Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Self-administered Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Self-administered Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Self-administered Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Self-administered Drugs Market Size by Type
8.2.1 Asia Pacific Self-administered Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Self-administered Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Self-administered Drugs Market Size by Application
8.3.1 Asia Pacific Self-administered Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Self-administered Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Self-administered Drugs Market Size by Region
8.4.1 Asia Pacific Self-administered Drugs Sales by Region
8.4.2 Asia Pacific Self-administered Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Self-administered Drugs Sales Breakdown by Company
9.1.1 Latin America Self-administered Drugs Sales by Company (2017-2022)
9.1.2 Latin America Self-administered Drugs Revenue by Company (2017-2022)
9.2 Latin America Self-administered Drugs Market Size by Type
9.2.1 Latin America Self-administered Drugs Sales by Type (2017-2028)
9.2.2 Latin America Self-administered Drugs Revenue by Type (2017-2028)
9.3 Latin America Self-administered Drugs Market Size by Application
9.3.1 Latin America Self-administered Drugs Sales by Application (2017-2028)
9.3.2 Latin America Self-administered Drugs Revenue by Application (2017-2028)
9.4 Latin America Self-administered Drugs Market Size by Country
9.4.1 Latin America Self-administered Drugs Sales by Country (2017-2028)
9.4.2 Latin America Self-administered Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Self-administered Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Self-administered Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Self-administered Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Self-administered Drugs Market Size by Type
10.2.1 Middle East and Africa Self-administered Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Self-administered Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Self-administered Drugs Market Size by Application
10.3.1 Middle East and Africa Self-administered Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Self-administered Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Self-administered Drugs Market Size by Country
10.4.1 Middle East and Africa Self-administered Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Self-administered Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Self-administered Drugs Products and Services
11.1.5 Abbott Laboratories Self-administered Drugs SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Self-administered Drugs Products and Services
11.2.5 Bristol-Myers Squibb Self-administered Drugs SWOT Analysis
11.2.6 Bristol-Myers Squibb Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Novartis AG Self-administered Drugs Products and Services
11.3.5 Novartis AG Self-administered Drugs SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Self-administered Drugs Products and Services
11.4.5 Eli Lilly and Company Self-administered Drugs SWOT Analysis
11.4.6 Eli Lilly and Company Recent Developments
11.5 Gilead Sciences
11.5.1 Gilead Sciences Corporation Information
11.5.2 Gilead Sciences Overview
11.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Gilead Sciences Self-administered Drugs Products and Services
11.5.5 Gilead Sciences Self-administered Drugs SWOT Analysis
11.5.6 Gilead Sciences Recent Developments
11.6 Antares Pharma
11.6.1 Antares Pharma Corporation Information
11.6.2 Antares Pharma Overview
11.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Antares Pharma Self-administered Drugs Products and Services
11.6.5 Antares Pharma Self-administered Drugs SWOT Analysis
11.6.6 Antares Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Self-administered Drugs Value Chain Analysis
12.2 Self-administered Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Self-administered Drugs Production Mode & Process
12.4 Self-administered Drugs Sales and Marketing
12.4.1 Self-administered Drugs Sales Channels
12.4.2 Self-administered Drugs Distributors
12.5 Self-administered Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Self-administered Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Self-administered Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Injectable Drugs
Table 3. Major Manufacturers of Inhaled Drugs
Table 4. Major Manufacturers of Transdermal Drugs
Table 5. Global Self-administered Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Self-administered Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Self-administered Drugs Sales by Region (2017-2022) & (K MT)
Table 8. Global Self-administered Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Self-administered Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Self-administered Drugs Revenue Market Share by Region (2017-2022)
Table 11. Global Self-administered Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 12. Global Self-administered Drugs Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Self-administered Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Self-administered Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Self-administered Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Self-administered Drugs Market Trends
Table 17. Self-administered Drugs Market Drivers
Table 18. Self-administered Drugs Market Challenges
Table 19. Self-administered Drugs Market Restraints
Table 20. Global Self-administered Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 21. Global Self-administered Drugs Sales Share by Manufacturers (2017-2022)
Table 22. Global Self-administered Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Self-administered Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 24. Self-administered Drugs Revenue Share by Manufacturers (2017-2022)
Table 25. Global Self-administered Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Self-administered Drugs as of 2021)
Table 27. Key Manufacturers Self-administered Drugs Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 28. Key Manufacturers Self-administered Drugs Plants/Factories Distribution
Table 29. Key Manufacturers Self-administered Drugs Area Served
Table 30. Date of Key Manufacturers Enter into Self-administered Drugs Market
Table 31. Key Manufacturers Self-administered Drugs Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Self-administered Drugs Sales (K MT) by Type (2017-2022)
Table 34. Global Self-administered Drugs Sales Share by Type (2017-2022)
Table 35. Global Self-administered Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Self-administered Drugs Price (K MT) by Type (2017-2022)
Table 37. Global Self-administered Drugs Sales (K MT) by Type (2023-2028)
Table 38. Global Self-administered Drugs Sales Share by Type (2023-2028)
Table 39. Global Self-administered Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Self-administered Drugs Revenue Share by Type (2023-2028)
Table 41. Global Self-administered Drugs Price (K MT) by Type (2023-2028)
Table 42. Global Self-administered Drugs Sales (K MT) by Application (2017-2022)
Table 43. Global Self-administered Drugs Sales Share by Application (2017-2022)
Table 44. Global Self-administered Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Self-administered Drugs Price (K MT) by Application (2017-2022)
Table 46. Global Self-administered Drugs Sales (K MT) by Application (2023-2028)
Table 47. Global Self-administered Drugs Sales Share by Application (2023-2028)
Table 48. Global Self-administered Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Self-administered Drugs Revenue Share by Application (2023-2028)
Table 50. Global Self-administered Drugs Price (K MT) by Application (2023-2028)
Table 51. North America Self-administered Drugs Sales by Company (2017-2022) & (K MT)
Table 52. North America Self-administered Drugs Sales Market Share by Company (2017-2022)
Table 53. North America Self-administered Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Self-administered Drugs Revenue Market Share by Company (2017-2022)
Table 55. North America Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 56. North America Self-administered Drugs Sales by Type (2023-2028) & (K MT)
Table 57. North America Self-administered Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Self-administered Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 60. North America Self-administered Drugs Sales by Application (2023-2028) & (K MT)
Table 61. North America Self-administered Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Self-administered Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 64. North America Self-administered Drugs Sales by Country (2023-2028) & (K MT)
Table 65. North America Self-administered Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Self-administered Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Self-administered Drugs Sales by Company (2017-2022) & (K MT)
Table 68. Europe Self-administered Drugs Sales Market Share by Company (2017-2022)
Table 69. Europe Self-administered Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Self-administered Drugs Revenue Market Share by Company (2017-2022)
Table 71. Europe Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 72. Europe Self-administered Drugs Sales by Type (2023-2028) & (K MT)
Table 73. Europe Self-administered Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Self-administered Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 76. Europe Self-administered Drugs Sales by Application (2023-2028) & (K MT)
Table 77. Europe Self-administered Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Self-administered Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 80. Europe Self-administered Drugs Sales by Country (2023-2028) & (K MT)
Table 81. Europe Self-administered Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Self-administered Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Self-administered Drugs Sales by Company (2017-2022) & (K MT)
Table 84. Asia Pacific Self-administered Drugs Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Self-administered Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Self-administered Drugs Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 88. Asia Pacific Self-administered Drugs Sales by Type (2023-2028) & (K MT)
Table 89. Asia Pacific Self-administered Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Self-administered Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 92. Asia Pacific Self-administered Drugs Sales by Application (2023-2028) & (K MT)
Table 93. Asia Pacific Self-administered Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Self-administered Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Self-administered Drugs Sales by Region (2017-2022) & (K MT)
Table 96. Asia Pacific Self-administered Drugs Sales by Region (2023-2028) & (K MT)
Table 97. Asia Pacific Self-administered Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Self-administered Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Self-administered Drugs Sales by Company (2017-2022) & (K MT)
Table 100. Latin America Self-administered Drugs Sales Market Share by Company (2017-2022)
Table 101. Latin America Self-administered Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Self-administered Drugs Revenue Market Share by Company (2017-2022)
Table 103. Latin America Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 104. Latin America Self-administered Drugs Sales by Type (2023-2028) & (K MT)
Table 105. Latin America Self-administered Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Self-administered Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 108. Latin America Self-administered Drugs Sales by Application (2023-2028) & (K MT)
Table 109. Latin America Self-administered Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Self-administered Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 112. Latin America Self-administered Drugs Sales by Country (2023-2028) & (K MT)
Table 113. Latin America Self-administered Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Self-administered Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Self-administered Drugs Sales by Company (2017-2022) & (K MT)
Table 116. Middle East and Africa Self-administered Drugs Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Self-administered Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Self-administered Drugs Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 120. Middle East and Africa Self-administered Drugs Sales by Type (2023-2028) & (K MT)
Table 121. Middle East and Africa Self-administered Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Self-administered Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 124. Middle East and Africa Self-administered Drugs Sales by Application (2023-2028) & (K MT)
Table 125. Middle East and Africa Self-administered Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Self-administered Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 128. Middle East and Africa Self-administered Drugs Sales by Country (2023-2028) & (K MT)
Table 129. Middle East and Africa Self-administered Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Self-administered Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 131. Abbott Laboratories Corporation Information
Table 132. Abbott Laboratories Description and Overview
Table 133. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 134. Abbott Laboratories Self-administered Drugs Product and Services
Table 135. Abbott Laboratories Self-administered Drugs SWOT Analysis
Table 136. Abbott Laboratories Recent Developments
Table 137. Bristol-Myers Squibb Corporation Information
Table 138. Bristol-Myers Squibb Description and Overview
Table 139. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 140. Bristol-Myers Squibb Self-administered Drugs Product and Services
Table 141. Bristol-Myers Squibb Self-administered Drugs SWOT Analysis
Table 142. Bristol-Myers Squibb Recent Developments
Table 143. Novartis AG Corporation Information
Table 144. Novartis AG Description and Overview
Table 145. Novartis AG Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 146. Novartis AG Self-administered Drugs Product and Services
Table 147. Novartis AG Self-administered Drugs SWOT Analysis
Table 148. Novartis AG Recent Developments
Table 149. Eli Lilly and Company Corporation Information
Table 150. Eli Lilly and Company Description and Overview
Table 151. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 152. Eli Lilly and Company Self-administered Drugs Product and Services
Table 153. Eli Lilly and Company Self-administered Drugs SWOT Analysis
Table 154. Eli Lilly and Company Recent Developments
Table 155. Gilead Sciences Corporation Information
Table 156. Gilead Sciences Description and Overview
Table 157. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 158. Gilead Sciences Self-administered Drugs Product and Services
Table 159. Gilead Sciences Self-administered Drugs SWOT Analysis
Table 160. Gilead Sciences Recent Developments
Table 161. Antares Pharma Corporation Information
Table 162. Antares Pharma Description and Overview
Table 163. Antares Pharma Self-administered Drugs Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 164. Antares Pharma Self-administered Drugs Product and Services
Table 165. Antares Pharma Self-administered Drugs SWOT Analysis
Table 166. Antares Pharma Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Self-administered Drugs Distributors List
Table 170. Self-administered Drugs Customers List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Self-administered Drugs Product Picture
Figure 2. Global Self-administered Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Injectable Drugs Product Picture
Figure 4. Inhaled Drugs Product Picture
Figure 5. Transdermal Drugs Product Picture
Figure 6. Global Self-administered Drugs Sales Market Share by Application in 2021 & 2028
Figure 7. Cardiovascular Diseases Use Case
Figure 8. Diabetes Use Case
Figure 9. Osteoporosis Use Case
Figure 10. Pain Management Use Case
Figure 11. Hormone Replacement Use Case
Figure 12. Others Use Case
Figure 13. Self-administered Drugs Report Years Considered
Figure 14. Global Self-administered Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Self-administered Drugs Market Size 2017-2028 (US$ Million)
Figure 16. Global Self-administered Drugs Sales (2017-2022) & (K MT)
Figure 17. Global Self-administered Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global Self-administered Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Self-administered Drugs Sales Market Share by Region in 2021
Figure 20. Global Self-administered Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 21. Global Self-administered Drugs Sales Share by Manufacturers in 2021
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Self-administered Drugs Sales in 2021
Figure 23. Self-administered Drugs Revenue Share by Manufacturers in 2021
Figure 24. Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 25. Global Self-administered Drugs Revenue Share by Type (2017-2022)
Figure 26. Global Self-administered Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 27. Global Self-administered Drugs Revenue Share by Application (2017-2022)
Figure 28. Global Self-administered Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 29. North America Self-administered Drugs Sales Market Share by Type (2017-2028)
Figure 30. North America Self-administered Drugs Revenue Market Share by Type (2017-2028)
Figure 31. North America Self-administered Drugs Sales Market Share by Application (2017-2028)
Figure 32. North America Self-administered Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Self-administered Drugs Sales Share by Country (2017-2028)
Figure 34. North America Self-administered Drugs Revenue Share by Country (2017-2028)
Figure 35. U.S. Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 36. Canada Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 37. Europe Self-administered Drugs Sales Market Share by Type (2017-2028)
Figure 38. Europe Self-administered Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Europe Self-administered Drugs Sales Market Share by Application (2017-2028)
Figure 40. Europe Self-administered Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Europe Self-administered Drugs Sales Share by Country (2017-2028)
Figure 42. Europe Self-administered Drugs Revenue Share by Country (2017-2028)
Figure 43. Germany Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. France Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. U.K. Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Italy Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Russia Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Asia Pacific Self-administered Drugs Sales Market Share by Type (2017-2028)
Figure 49. Asia Pacific Self-administered Drugs Revenue Market Share by Type (2017-2028)
Figure 50. Asia Pacific Self-administered Drugs Sales Market Share by Application (2017-2028)
Figure 51. Asia Pacific Self-administered Drugs Revenue Market Share by Application (2017-2028)
Figure 52. Asia Pacific Self-administered Drugs Sales Share by Region (2017-2028)
Figure 53. Asia Pacific Self-administered Drugs Revenue Share by Region (2017-2028)
Figure 54. China Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Japan Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. South Korea Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. India Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Australia Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Taiwan Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Indonesia Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Thailand Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Malaysia Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Philippines Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Vietnam Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Latin America Self-administered Drugs Sales Market Share by Type (2017-2028)
Figure 66. Latin America Self-administered Drugs Revenue Market Share by Type (2017-2028)
Figure 67. Latin America Self-administered Drugs Sales Market Share by Application (2017-2028)
Figure 68. Latin America Self-administered Drugs Revenue Market Share by Application (2017-2028)
Figure 69. Latin America Self-administered Drugs Sales Share by Country (2017-2028)
Figure 70. Latin America Self-administered Drugs Revenue Share by Country (2017-2028)
Figure 71. Mexico Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Brazil Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Argentina Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Middle East and Africa Self-administered Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Self-administered Drugs Revenue Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Self-administered Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Self-administered Drugs Revenue Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Self-administered Drugs Sales Share by Country (2017-2028)
Figure 79. Middle East and Africa Self-administered Drugs Revenue Share by Country (2017-2028)
Figure 80. Turkey Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Saudi Arabia Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. UAE Self-administered Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Self-administered Drugs Value Chain
Figure 84. Self-administered Drugs Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Keyplayers in Global Self-administered Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Abbott LaboratoriesBristol-Myers Squibb
Novartis AG
Eli Lilly and Company
Gilead Sciences
Antares Pharma